A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
Main Authors: | Takamura, Etsuko, Tsubota, Kazuo, Watanabe, Hitoshi, Ohashi, Yuichi |
---|---|
Format: | Online |
Language: | English |
Published: |
BMJ Group
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463860/ |
Similar Items
-
Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
by: Koh, Shizuka
Published: (2015) -
Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study
by: Yamaguchi, Masahiko, et al.
Published: (2015) -
Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
by: Yamane, Mio, et al.
Published: (2015) -
Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
by: Nagahara, Yukiko, et al.
Published: (2015) -
Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease
by: Yongseok Mun, et al.
Published: (2018-09-01)